Corcept Therapeutics Inc (CORT)

Add to Watchlists
Create an Alert
12.99 +0.33  +2.61% NASDAQ Aug 16, 20:00 Delayed 2m USD

Corcept Therapeutics Revenue (Quarterly):

72.26M for June 30, 2019
View 4,000+ financial data types
Browse...
View Full Chart

Revenue (Quarterly) Chart

Export Data
Save Image
Print Image

Historical Revenue (Quarterly) Data

View and export this data going back to 2003. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
June 30, 2019 72.26M
March 31, 2019 64.83M
Dec. 31, 2018 66.83M
Sept. 30, 2018 64.44M
June 30, 2018 62.31M
March 31, 2018 57.66M
Dec. 31, 2017 53.28M
Sept. 30, 2017 42.76M
June 30, 2017 35.56M
March 31, 2017 27.60M
Dec. 31, 2016 23.81M
Sept. 30, 2016 21.72M
June 30, 2016 19.72M
March 31, 2016 16.06M
Dec. 31, 2015 14.97M
Sept. 30, 2015 13.26M
June 30, 2015 11.96M
March 31, 2015 10.10M
Dec. 31, 2014 9.014M
Sept. 30, 2014 7.282M
June 30, 2014 5.851M
March 31, 2014 4.405M
Dec. 31, 2013 4.115M
Sept. 30, 2013 2.634M
June 30, 2013 1.891M
   
March 31, 2013 1.717M
Dec. 31, 2012 1.377M
Sept. 30, 2012 1.055M
June 30, 2012 0.875M
March 31, 2012
Dec. 31, 2011
Sept. 30, 2011
June 30, 2011
March 31, 2011
Dec. 31, 2010
Sept. 30, 2010
June 30, 2010
March 31, 2010
Dec. 31, 2009
Sept. 30, 2009
June 30, 2009 0.006M
March 31, 2009 0.024M
Dec. 31, 2008 0.143M
Sept. 30, 2008 0.066M
June 30, 2008
March 31, 2008
Dec. 31, 2007
Sept. 30, 2007
June 30, 2007 0.374M
March 31, 2007 0.108M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Revenues

Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity. Increasing revenues over time are generally a good sign of company's growth.

While a bit obvious, if a lemonade company has sold 30 million in revenue and has 10 million in costs of goods sold, the company's revenue is still 30 million. (Expenses are not accounted in Revenue).
Learn More

Advertisement

Revenue (Quarterly) Benchmarks

Benchmarks
Celgene Corp 4.40B
Amgen Inc 5.871B
Ekso Bionics Holdings Inc 3.262M

Revenue (Quarterly) Range, Past 5 Years

Minimum 7.282M Sep 2014
Maximum 72.26M Jun 2019
Average 34.77M

Revenue (Quarterly) Excel Add-In Codes

  • Metric Code: revenues
  • Data Point Example: =YCP("CORT", "revenues")
  • Data Series Example: =YCS("CORT", "revenues", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.